Lifevantage (LFVN) EBT Margin (2010 - 2026)
Lifevantage's (LFVN) quarterly EBT Margin came in at 26.92% in Q2 2026, up 2257.0% on a YoY basis from 1.14% in Q2 2025, and up 610.67% quarter-over-quarter from 3.79% in Q1 2026.
Analysis
Lifevantage (LFVN) EBT Margin (2010 - 2026) Analysis & Trends
Lifevantage (LFVN) has reported EBT Margin for 17 consecutive years, with 26.92% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 2257.0% year-over-year to 26.92%; the trailing twelve-month figure through Jun 2026 stood at 4.14% (down 122.0% YoY), and the FY2026 full-year result was 3.32%, down 204.0% from the prior year.
- EBT Margin climbed to 26.92% in Q2 2026 per LFVN's latest filing, from 3.79% in the prior quarter.
- Across five years, EBT Margin topped out at 26.92% in Q2 2026 and bottomed at 2.15% in Q4 2023.
- Historically, EBT Margin has averaged 4.22% across 5 years, with a median of 3.88% in 2024.
- The sharpest annual moves came in 2022 and 2026: EBT Margin slumped 1378 bps in 2022, then soared 2257 bps in 2026.
- Over 5 years, EBT Margin stood at 2.0% in 2022, then retreated by 8 bps to 2.15% in 2023, then soared by 312 bps to 4.56% in 2024, then slumped by 79 bps to 0.97% in 2025, then soared by 2685 bps to 26.92% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 26.92%, 3.79%, and 0.97% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.54 Bn | 69.17 Bn | 3.30 Bn | 17.72% |
| 2 | Kenvue | 34.21 Bn | 33.10 Bn | 2.30 Bn | 15.12% |
| 3 | Kimberly Clark | 32.84 Bn | 31.89 Bn | 1.60 Bn | 13.65% |
| 4 | Bath & Body Works | 3.74 Bn | 2.95 Bn | 692.00 Mn | 10.83% |
| 5 | Prestige Consumer Healthcare | 2.29 Bn | 2.23 Bn | - | - |
| 6 | Perrigo | 1.92 Bn | 1.52 Bn | 313.90 Mn | 10.31% |
| 7 | Herbalife | 1.28 Bn | 912.76 Mn | 1.03 Bn | -0.28% |
| 8 | Edgewell Personal Care | 1.22 Bn | 819.71 Mn | 242.50 Mn | 3.16% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Lifevantage | 79.87 Mn | 64.95 Mn | 33.04 Mn | 26.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.92% |
| Mar 31, 2026 | 3.79% |
| Dec 31, 2025 | 0.97% |
| Sep 30, 2025 | 4.71% |
| Jun 30, 2025 | 4.35% |
| Mar 31, 2025 | 7.15% |
| Dec 31, 2024 | 4.56% |
| Sep 30, 2024 | 5.46% |
| Jun 30, 2024 | 5.54% |
| Mar 31, 2024 | 3.98% |
| Dec 31, 2023 | -2.15% |
| Sep 30, 2023 | 1.61% |
| Jun 30, 2023 | 4.71% |
| Mar 31, 2023 | 3.10% |
| Dec 31, 2022 | -2.00% |
| Sep 30, 2022 | 1.65% |
| Jun 30, 2022 | -1.95% |
| Mar 31, 2022 | 3.50% |
| Dec 31, 2021 | -0.95% |
| Sep 30, 2021 | 8.33% |